The specific expression of Hypoxia Inducible Factor-1α in human gastric mucosa induced by nonsteroidal anti-inflammatory drugs

被引:19
作者
Ito, M
Tanaka, S
Kim, S
Kuwai, T
Matsutani, N
Kamada, T
Kitadai, Y
Sumii, M
Yoshihara, M
Haruma, K
Chayama, K
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan
[3] Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol 2, Kurashiki, Okayama, Japan
[4] Hiroshima Univ, Hlth Serv Ctr, Higashihiroshima 724, Japan
关键词
D O I
10.1046/j.1365-2036.18.s1.10.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Hypoxia is a cause of gastric mucosal damage induced by nonsteroidal anti-inflammatory drugs (NSAIDs). The expression of hypoxia inducible factor-1alpha (HIF-1alpha) reflects the status of tissue ischaemia. Aim: To investigate the effect of NSAID administration on the expression of HIF-1alpha in human gastric mucosa. Methods: We employed 71 patients including 14 with NSAID administration. The HIF-1alpha expression was estimated by immunohistochemistry using monoclonal antibody (H1alpha67) and raised antiserum (HI-3). Vascular endothelial growth factor expression was also examined by immunohistochemistry. HI-3 recognized hypoxia-induced protein in HeLa cells. Results: In human gastric mucosa, HIF-1alpha was mainly expressed in the nuclei of the surface epithelial cells and in the neck zone both by use of HI-3 and of H1alpha67. The expression of vascular endothelial growth factor correlated well with that of HIF-1alpha. The level of HIF-1alpha in the surface epithelium was significantly higher in patients with administration of NSAIDs than those without NSAID use (P < 0.001) both in the gastric corpus and antrum. Helicobacter pylori infection did not affected the levels of HIF-1 alpha. Long-term administration of rebamipide reduced the level of HIF-1 alpha. Conclusion: HIF-1 alpha expression is a new biological marker of ischaemia especially in NSAID-related gastric lesions.
引用
收藏
页码:90 / 98
页数:9
相关论文
共 37 条
[1]   MODULATION OF LEUKOCYTE ADHESION IN RAT MESENTERIC VENULES BY ASPIRIN AND SALICYLATE [J].
ASAKO, H ;
KUBES, P ;
WALLACE, J ;
WOLF, RE ;
GRANGER, DN .
GASTROENTEROLOGY, 1992, 103 (01) :146-152
[2]   Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs:: a randomised trial [J].
Chan, FKL ;
To, KF ;
Wu, JCY ;
Yung, MY ;
Leung, WK ;
Kwok, T ;
Hui, Y ;
Chan, HLY ;
Chan, CSY ;
Hui, E ;
Woo, J ;
Sung, JJY .
LANCET, 2002, 359 (9300) :9-13
[3]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[4]   Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia [J].
Dixon, MF .
GUT, 2001, 49 (01) :2-4
[5]   Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis [J].
Faller, G ;
Steininger, H ;
Kranzlein, J ;
Maul, H ;
Kerkau, T ;
Hensen, J ;
Hahn, EG ;
Kirchner, T .
GUT, 1997, 41 (05) :619-623
[6]   Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils [J].
Han, BG ;
Kim, HS ;
Rhee, KH ;
Han, HS ;
Chung, MH .
PHARMACOLOGICAL RESEARCH, 1995, 32 (04) :201-207
[7]   Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer in Japan [J].
Haruma, K .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2000, 29 (03) :623-+
[8]   Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis [J].
Haruma, K ;
Ito, M ;
Kido, S ;
Manabe, N ;
Kitadai, Y ;
Sumii, M ;
Tanaka, S ;
Yoshihara, M ;
Chayama, K .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (04) :862-867
[9]   Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs:: HELP NSAIDs study [J].
Hawkey, CJ ;
Tulassay, Z ;
Szczepanski, L ;
van Rensburg, CJ ;
Filipowicz-Sosnowska, A ;
Lanas, A ;
Wason, CM ;
Peacock, RA ;
Gillon, KRW .
LANCET, 1998, 352 (9133) :1016-1021
[10]   Role of Helicobacter pylori infection and non-steroidal antiinflammatory drugs in peptic-ulcer disease:: a meta-analysis [J].
Huang, JQ ;
Sridhar, S ;
Hunt, RH .
LANCET, 2002, 359 (9300) :14-22